Chan P
Department of Clinical Pharmacology and Vascular Surgery, St Mary's Hospital, London.
Ann R Coll Surg Engl. 1994 Sep;76(5):298-303.
Vascular smooth muscle is the cellular substrate of most significant arterial diseases. Restenosis after angioplasty and surgery mainly represents vascular smooth muscle reaction to trauma, a process which is also significant in the early stages of atherogenesis. Empirical approaches, based on findings in animal models of vascular injury, have notably failed to make any impact on human restenosis. We have developed and validated growth of the human VSMC in culture as a model of restenosis. Intimal hyperplastic lesions producing vascular restenosis contain cells that have reduced sensitivity to physiological growth inhibition by heparin in cell culture conditions, compared with cells from normal vascular tissue. Undiseased saphenous vein obtained from patients with intimal hyperplastic restenoses also contain cells that are relatively resistant to heparin inhibition. Arterial healing that progresses to restenosis may have distinct and fundamental differences at the cellular level from the normal process of arterial healing after injury.
血管平滑肌是大多数重要动脉疾病的细胞基础。血管成形术和手术后的再狭窄主要表现为血管平滑肌对创伤的反应,这一过程在动脉粥样硬化形成的早期阶段也很重要。基于血管损伤动物模型研究结果的经验性方法,在人类再狭窄方面显然未能产生任何影响。我们已经开发并验证了在培养中人类血管平滑肌细胞的生长作为再狭窄的模型。与正常血管组织的细胞相比,产生血管再狭窄的内膜增生性病变中的细胞在细胞培养条件下对肝素的生理性生长抑制敏感性降低。从内膜增生性再狭窄患者获得的未患病的大隐静脉也含有对肝素抑制相对耐药的细胞。进展为再狭窄的动脉愈合在细胞水平上可能与损伤后动脉愈合的正常过程存在明显且根本的差异。